Consensus for Nonmelanoma Skin Cancer Treatment, Part II: Squamous Cell Carcinoma, Including a Cost Analysis of

Arielle N B Kauvar1, Christopher J Arpey, George Hruza

  • 1*New York University School of Medicine, New York, New York; †New York Laser & Skin Care, New York, New York; ‡Mayo Clinic, Rochester, Minnesota; §St. Louis University, St Louis, Missouri; ‖Laser & Dermatologic Surgery Center, Chesterfield, Missouri; ¶Lahey Clinic; Associate Professor, Harvard Medical School, Boston, Massachusetts; #David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California; **Keck School of Medicine, University of Southern California, Los Angeles, California.

Summary

For cutaneous squamous cell carcinoma (cSCC), Mohs surgery offers the best cure rates and cosmetic outcomes. While other treatments exist, surgery is preferred for high-risk cSCC, balancing cure with patient factors.

Related Concept Videos

Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
6.6K
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
832
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K